Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation.

Correll, Christoph U; Jain, Rakesh; Meyer, Jonathan M; Periclou, Antonia; Carrothers, Timothy; Barabássy, Ágota; Patel, Mehul; Earley, Willie

Correll, Christoph U; Jain, Rakesh; Meyer, Jonathan M; Periclou, Antonia; Carrothers, Timothy; Barabássy, Ágota; Patel, Mehul; Earley, Willie.

Afiliação

Correll CU; Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, USA.
Jain R; Hofstra Northwell School of Medicine, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA.
Meyer JM; Charité Universitätsmedizin, Department of Child and Adolescent Psychiatry, Berlin, Germany.
Periclou A; Texas Tech University School of Medicine - Permian Basin, Department of Psychiatry, Midland, TX, USA.
Carrothers T; University of California, San Diego School of Medicine, Department of Psychiatry, La Jolla, CA, USA.
Barabássy Á; Allergan, Department of Clinical Pharmacology, Madison, NJ, USA.
Patel M; Allergan, Department of Clinical Pharmacology, Madison, NJ, USA.
Earley W; Department of Medical Affairs, Gedeon Richter Plc, Budapest, Hungary.

Neuropsychiatr Dis Treat ; 15: 2537-2550, 2019.

Article em En | MEDLINE | ID: mdl-31507322